Zobrazeno 1 - 10
of 1 206
pro vyhledávání: '"Gorvel L"'
Autor:
Wlosik J; Team 'Immunity and Cancer', Marseille Cancer Research Center, Inserm U1068, CNRS UMR7258, Paoli-Calmettes Institute, Aix-Marseille University UM105, Marseille, France.; Immunomonitoring Department, Paoli-Calmettes Institute, Marseille, France., Granjeaud S; Systems Biology Platform, Marseille Cancer Research Center, Inserm U1068, CNRS UMR7258, Paoli-Calmettes Institute, Aix-Marseille University UM105, Marseille, France., Gorvel L; Team 'Immunity and Cancer', Marseille Cancer Research Center, Inserm U1068, CNRS UMR7258, Paoli-Calmettes Institute, Aix-Marseille University UM105, Marseille, France.; Immunomonitoring Department, Paoli-Calmettes Institute, Marseille, France., Olive D; Team 'Immunity and Cancer', Marseille Cancer Research Center, Inserm U1068, CNRS UMR7258, Paoli-Calmettes Institute, Aix-Marseille University UM105, Marseille, France.; Immunomonitoring Department, Paoli-Calmettes Institute, Marseille, France., Chretien AS; Team 'Immunity and Cancer', Marseille Cancer Research Center, Inserm U1068, CNRS UMR7258, Paoli-Calmettes Institute, Aix-Marseille University UM105, Marseille, France.; Immunomonitoring Department, Paoli-Calmettes Institute, Marseille, France.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2024 Nov 01. Date of Electronic Publication: 2024 Nov 01.
Autor:
Kerneur C; ImCheck Therapeutics, R&D Department, 13009 Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France., Foucher E; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Guillén Casas J; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Colazet M; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Le KS; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Fullana M; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Bergot E; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Audemard C; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Drapeau M; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Louche P; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Gorvel L; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France., Rouvière MS; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France., Boucherit N; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France., Audebert S; Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille Protéomique, Marseille, France., Magrini E; IRCCS, Humanitas Research Hospital, 20089 Rozzano, Italy., Carnevale S; IRCCS, Humanitas Research Hospital, 20089 Rozzano, Italy., de Gassart A; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Madakamutil L; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Mantovani A; IRCCS, Humanitas Research Hospital, 20089 Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy; William Harvey Research Institute, Queen Mary University, London EC1M 6BQ, UK., Garlanda C; IRCCS, Humanitas Research Hospital, 20089 Rozzano, Italy., Agaugué S; ImCheck Therapeutics, R&D Department, 13009 Marseille, France., Cano CE; ImCheck Therapeutics, R&D Department, 13009 Marseille, France. Electronic address: carla.cano@imcheck.fr., Olive D; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France. Electronic address: daniel.olive@inserm.fr.
Publikováno v:
Cell reports [Cell Rep] 2024 Oct 22; Vol. 43 (10), pp. 114773. Date of Electronic Publication: 2024 Sep 25.
Autor:
Le Floch AC; Centre de Recherche en Cancérologie de Marseille, Marseille, France., Imbert C; Centre de Recherche en Cancérologie de Marseille, Toulouse cedex 1, France., Boucherit N; Centre de Recherche en Cancérologie de Marseille, Marseille, France., Gorvel L; Centre de Recherche en Cancérologie de Marseille, Marseille, France., Fattori S; Centre de Recherche en Cancérologie de Marseille, Marseille, France., Orlanducci F; Centre de Recherche en Cancérologie de Marseille, Marseille, France., Le Roy A; Alderaan Biotechnology, Paris, France., Archetti L; Nanolive SA, Switzerland., Crescence L; Aix-Marseille University, Marseille, France., Panicot-Dubois L; Aix-Marseille University, Marseille, France., Dubois C; Aix-Marseille University, Marseille, France., Vey N; Institute Paoli-Calmettes, France., Briantais A; Centre de Recherche en Cancérologie de Marseille, France., Anastasio A; Centre de Recherche en Cancérologie de Marseille, France., Cano C; ImCheck Therapeutics, France., Guittard G; Centre de Recherche en Cancérologie de Marseille, Marseille, France., Frechin M; Nanolive SA, Switzerland., Olive D; Institute Paoli-Calmettes, Marseille, France.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Sep 20. Date of Electronic Publication: 2024 Sep 20.
Autor:
Gay L; Institut de recherche pour le developpement (IRD), Assistance-Publique Hopitaux de Marseille (APHM), Microbes Evolution Phylogénie et Infections (MEPHI), Aix-Marseille University, Marseille, France.; ImCheck Therapeutics, Marseille, France., Rouviere MS; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Institut Paoli Calmettes, Marseille, France., Mezouar S; Etablissement Français du Sang, Centre National de la Recherche Scientifique, Anthropologie Bio-Culturelle, Droit, Éthique et Santé, 'Biologie des Groupes Sanguins,' Aix-Marseille University, Marseille, France., Richaud M; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Institut Paoli Calmettes, Marseille, France., Gorvel L; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Institut Paoli Calmettes, Marseille, France., Foucher E; ImCheck Therapeutics, Marseille, France., La Scola B; Institut de recherche pour le developpement (IRD), Assistance-Publique Hopitaux de Marseille (APHM), Microbes Evolution Phylogénie et Infections (MEPHI), Aix-Marseille University, Marseille, France., Menard A; Unité COVID-Long, Service de Médecine Interne, Centre Hospitalo-Universitaire Nord (CHU NORD), Assistance-Publique Hopitaux de Marseille (APHM), Marseille, France., Allardet-Servent J; Service de Réanimation, Hôpital Européen, Marseille, France., Halfon P; Département de Médecine Interne et Maladies Infectieuses, Hôpital Européen-Laboratoire Alphabio-Biogroup, Marseille, France., Frohna P; ImCheck Therapeutics, Marseille, France., Cano C; ImCheck Therapeutics, Marseille, France., Mege JL; Institut de recherche pour le developpement (IRD), Assistance-Publique Hopitaux de Marseille (APHM), Microbes Evolution Phylogénie et Infections (MEPHI), Aix-Marseille University, Marseille, France.; Assistance-Publique Hopitaux de Marseille (APHM), Hôpital de la Conception, Laboratoire d'Immunologie, Aix-Marseille University, Marseille, France., Olive D; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Institut Paoli Calmettes, Marseille, France.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Jun 14; Vol. 229 (6), pp. 1759-1769.
Autor:
Kfoury, M., Pesce, F., Provansal Gross, M., Charafe, E., Gorvel, L., Rousseau, F., Cappiello, M.A., Sabatier, R.
Publikováno v:
In Immuno-Oncology and Technology December 2023 20 Supplement
Autor:
Bertucci, A., Maby, P., Rochigneux, P., Legrand, F., Cropet, C., Frenel, J-S., Le Tourneau, C., Hervieu, A., Coquan, E., De La Motte Rouge, T., Saada, E.B., Lavaud, P., Ben-Amara, A., Rouvière, M-S., Grassi, P., Gorvel, L., Goncalves, A., Olive, D., Chrétien, A-S.
Publikováno v:
In Immuno-Oncology and Technology December 2023 20 Supplement
Autor:
Wiest MJ; Department of Immunology, Mayo Clinic, Scottsdale, AZ, United States., Baert L; Department of Immunology, Mayo Clinic, Scottsdale, AZ, United States., Gu C; Department of Immunology, Mayo Clinic, Scottsdale, AZ, United States., Gayler KM; Department of Chemistry and Biochemistry, Baylor University, Waco, TX, United States., Ham H; Department of Immunology, Mayo Clinic, Rochester, MN, United States., Gorvel L; CRCM, Aix Marseille Universite, INSERM, Marseille, France., Keddis MT; Department of Nephrology, Mayo Clinic, Scottsdale, AZ, United States., Griffing LW; Department of Rheumatology, Mayo Clinic, Scottsdale, AZ, United States., Joo H; Department of Immunology, Mayo Clinic, Scottsdale, AZ, United States.; Department of Chemistry and Biochemistry, Baylor University, Waco, TX, United States., Gorvel JP; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France., Billadeau DD; Department of Immunology, Mayo Clinic, Rochester, MN, United States., Kane RR; Department of Chemistry and Biochemistry, Baylor University, Waco, TX, United States., Oh S; Department of Immunology, Mayo Clinic, Scottsdale, AZ, United States.; Department of Chemistry and Biochemistry, Baylor University, Waco, TX, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1202197. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).
Autor:
Fattori S; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France., Le Roy A; Alderaan Biotechnology, Paris, France., Houacine J; Alderaan Biotechnology, Paris, France., Robert L; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France., Abes R; Alderaan Biotechnology, Paris, France., Gorvel L; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France., Granjeaud S; Systems Biology Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France., Rouvière MS; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France., Ben Amara A; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France., Boucherit N; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France., Tarpin C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Pakradouni J; Department of Clinical Research and Innovations, Institut Paoli-Calmettes, Marseille, France., Charafe-Jauffret E; Department of Pathology, Institut Paoli-Calmettes, Marseille, France.; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France., Houvenaeghel G; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France.; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France., Lambaudie E; Department of Pathology, Institut Paoli-Calmettes, Marseille, France.; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France., Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France., Rochigneux P; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France., Foussat A; Alderaan Biotechnology, Paris, France., Chrétien AS; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France.; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France., Olive D; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France.; Cancer Immunomonitoring Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Marseille, France.; Alderaan Biotechnology, Paris, France.; Faculty of Medical and Paramedic Sciences, Aix-Marseille University, UM105, Marseille, France.
Publikováno v:
Cancer research [Cancer Res] 2023 Sep 15; Vol. 83 (18), pp. 3026-3044.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Beaufils M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Amodru V; Department of Endocrinology, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France., Tejeda M; Department of Informatics, Institut Paoli-Calmettes, Marseille, France., Boher JM; Department of Biostatistics, Institut Paoli-Calmettes, Marseille, France., Zemmour C; Department of Biostatistics, Institut Paoli-Calmettes, Marseille, France., Chanez B; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Chrétien AS; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France., Gorvel L; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France., Gravis G; Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Bruyat D; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Mari R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Cuny T; Department of Endocrinology, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Lisberg AE; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA., Olive D; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France., Tassy L; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Castinetti F; Department of Endocrinology, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France., Rochigneux P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France rochigneuxp@ipc.unicancer.fr.; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).